The convergence of hormone regulation and cell cycle in prostate physiology and prostate tumorigenesis

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 22, Issue 2, 2002, Pages 129-138

  Davis, Joanne N ^a   Day, Mark L ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

Androgen receptor; Apoptosis; Cell cycle regulation; Hormone regulation; Prostate cancer; Retinoblastoma tumor suppressor protein (Rb)

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; RETINOBLASTOMA PROTEIN;

APOPTOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CARCINOGENESIS; CELL CYCLE; GENE FUNCTION; GENE INACTIVATION; GENE LOSS; GENE MUTATION; HORMONAL REGULATION; HUMAN; MALE; PROSTATE CANCER; REVIEW;

ANDROGENS; CELL CYCLE; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RETINOBLASTOMA PROTEIN;

EID: 0036800269     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1385/MB:22:2:129     Document Type: Review

References (84)

1. Greenlee, R. T., Hill-Harmon, M. B., Murray, T., and Thun, M. (2001) Cancer statistics. Cancer J. Clin. 51, 15-36.
2. Chiarodo, A. (1991) National Cancer Institute roundtable on prostate cancer: future research directions. Cancer Res. 51, 2498-2505.
3. Sensibar, J. A. (1995) Analysis of cell death and cell proliferation in embryonic stages, normal adult, and aging prostates in human and animals. Micro. Res. Tech. 30, 342-350.
4. Veldscholte, J., Berrevoets, C. A., Brinkmann, A. O., Grootegoed, J. A., and Mulder, E. (1992) Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation. Biochemistry 31, 2393-2399.
5. Ikonen, T., Palvimo, J. J., Kallio, P. J., Reinikainen, P., and Janne, O. A. (1994) Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Endocrinology 135, 1359-1366.
6. Kang, H. Y., Yeh, S., Fujimoto, N., and Chang, C. (1999) Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. J. Biol. Chem. 274, 8570-8576.
7. Heinlein, C. A., Ting, H. J., Yeh, S., and Chang, C. (1999) Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 274, 16147-16152.
8. Miyamoto, H., Yeh, S., Wilding, G., and Chang, C. (1998) Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. Proc. Natl. Acad. Sci. USA 95, 7379-7384.
9. Gittes, R. F. (1991) Carcinoma of the prostate. N. Engl. J. Med. 324, 236-245.
10. Palmberg, C., Koivisto, P., Visakorpi, T., and Tammela, T. L. (1999) PSA decline is an independent prognostic marker in hormonally treated prostate cancer. Eur. Urol. 36, 191-196.
11. Huggins, C. (1965) Two principles in endocrine therapy of cancers: hormone deprival and hormone interference. Cancer Res. 25, 1163-1167.
12. Mirosevich, J., Bentel, J. M., Zeps, N., Redmond, S. L., D'Antuono, M. F., and Dawkins, H. J. (1999) Androgen receptor expression of proliferating basal and luminal cells in adult murine ventral prostate. J. Endocrinol. 162, 341-350.
13. Kurita, T., Wang, Y. Z., Donjacour, A. A., Zhao, C., Lydon, J. P., O'Malley, B. W., Isaacs, J. T., Dahiya, R., and Cunha, G. R. (2001) Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system. Cell Death Differ. 8, 192-200.
14. Gao, J., Arnold, J. T., and Isaacs, J. T. (2001) Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells. Cancer Res. 61, 5038-5044.
15. Noble, R. L. (1982) Prostate carcinoma of the Nb rat in relation to hormones. Int. Rev. Exp. Pathol. 23, 113-159.
16. Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J. A. (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93, 5925-5930.
17. Leav, I., Lau, K. M., Adams, J. Y., McNeal, J. E., Taplin, M. E., Wang, J., Singh, H., and Ho, S. M. (2001) Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am. J. Pathol. 159, 79-92.
18. Lau, K. M., LaSpina, M., Long, J., and Ho, S. M. (2000) Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res. 60, 3175-3182.
19. Pasquali, D., Rossi, V., Esposito, D., Abbondanza, C., Puca, G. A., Bellastella, A., and Sinisi, A. A. (2001) Loss of estrogen receptor beta expression in malignant human prostate cells in primary cultures and in prostate cancer tissues. J. Clin. Endocrinol. Metab. 86, 2051-2055.
20. Weihua, Z., Makela, S., Andersson, L. C., Salmi, S., Saji, S., Webster, J. I., Jensen, E. V., Nilsson, S., Warner, M., and Gustafsson, J. A. (2001) A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc. Natl. Acad. Sci. USA 98, 6330-6335.
21. Xie, W., Wong, Y. C., and Tsao, S. W. (2000) Correlation of increased apoptosis and proliferation with development of prostatic intraepithelial neoplasia (PIN) in ventral prostate of the Noble rat. Prostate 44, 31-39.
22. Wang, Y., Hayward, S. W., Donjacour, A. A., Young, P., Jacks, T., Sage, J., Dahiya, R., Cardiff, R. D., Day, M. L., and Cunha, G. R. (2000) Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue. Cancer Res. 60, 6008-6017.
23. Ouyang, X. S., Wang, X., Lee, D. T., Tsao, S. W., and Wong, Y. C. (2001) Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat. Carcinogenesis 22, 965-973.
24. Asamoto, M., Hokaiwado, N., Cho, Y. M., Takahashi, S., Ikeda, Y., Imaida, K., and Shirai, T. (2001) Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent. Cancer Res. 61, 4693-4700.
25. Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinanen, R., Palmberg, C., Palotie, A., Tammela, T., Isola, J., and Kallioniemi, O. P. (1995) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat. Genet. 9, 401-406.
26. Taplin, M. E., Bubley, G. J., Shuster, T. D., Frantz, M. E., Spooner, A. E., Ogata, G. K., Keer, H. N., and Balk, S. P. (1995) Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N. Engl. J. Med. 332, 1393-1398.
27. Veldscholte, J., Ris-Stalpers, C., Kuiper, G. G., Jenster, G., Berrevoets, C., Claassen, E., van Rooij, H. C., Trapman, J., Brinkmann, A. O., and Mulder, E. (1990) A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys. Res. Commun. 173, 534-540.
28. Suzuki, H., Akakura, K., Komiya, A., Aida, S., Akimoto, S., and Shimazaki, J. (1996) Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome. Prostate 29, 153-158.
29. Tan, J., Sharief, Y., Hamil, K. G., Gregory, C. W., Zang, D. Y., Sar, M., Gumerlock, P. H., de Vere White, R. W., Pretlow, T. G., Harris, S. E., Wilson, E. M., Mohler, J. L., and French, F. S. (1997) Dehydro-epiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Mol. Endocrinol. 11, 450-459.
30. Taplin, M. E., Bubley, G. J., Ko, Y. J., Small, E. J., Upton, M., Rajeshkumar, B., and Balk, S. P. (1999) Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. Cancer Res. 59, 2511-2515.
31. Wang, C., Young, W. J., and Chang, C. (2000) Isolation and characterization of the androgen receptor mutants with divergent transcriptional activity in response to hydroxyflutamide. Endocrine 12, 69-76.
32. Koivisto, P., Kononen, J., Palmberg, C., Tammela, T., Hyytinen, E., Isola, J., Trapman, J., Cleutjens, K., Noordzij, A., Visakorpi, T., and Kallioniemi, O. P. (1997) Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res. 57, 314-319.
33. Miyoshi, Y., Uemura, H., Fujinami, K., Mikata, K., Harada, M., Kitamura, H., Koizumi, Y., and Kubota, Y. (2000) Fluorescence in situ hybridization evaluation of c-myc and androgen receptor gene amplification and chromosomal anomalies in prostate cancer in Japanese patients. Prostate 43, 225-232.
34. Bubendorf, L., Kononen, J., Koivisto, P., Schraml, P., Moch, H., Gasser, T. C., Willi, N., Mihatsch, M. J., Sauter, G., and Kallioniemi, O. P. (1999) Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res. 59, 803-806.
35. Culig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., and Klocker, H. (1994) Androgen receptor activation in prostatic tumor cell lines by insulin- like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res. 54, 5474-5478.
36. Fan, N. C., Jeung, E. B., Peng, C., Olofsson, J. I., Krisinger, J., and Leung, P. C. (1994) The human gonadotropin-releasing hormone (GnRH) receptor gene: cloning, genomic organization and chromosomal assignment. Mol. Cell. Endocrinol. 103, R1-6.
37. Lin, D. L., Whitney, M. C., Yao, Z., and Keller, E. T. (2001) Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression. Clin. Cancer Res. 7, 1773-1781.
38. Sadar, M. D. (1999) Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways. J. Biol. Chem. 274, 7777-7783.
39. Craft, N., Shostak, Y., Carey, M., and Sawyers, C. L. (1999) A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat. Med. 5, 280-285.
40. Yeh, S., Lin, H. K., Kang, H. Y., Thin, T. H., Lin, M. F., and Chang, C. (1999) From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc. Natl. Acad. Sci. USA 96, 5458-5463.
41. Abreu-Martin, M. T., Chari, A., Palladino, A. A., Craft, N. A., and Sawyers, C. L. (1999) Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer. Mol. Cell. Biol. 19, 5143-5154.
42. van der Kwast, T. H., Schalken, J., Ruizeveld de Winter, J. A., van Vroonhoven, C. C., Mulder, E., Boersma, W., and Trapman, J. (1991) Androgen receptors in endocrine-therapy-resistant human prostate cancer. Int. J. Cancer 48, 189-193.
43. Wolf, D. A., Herzinger, T., Hermeking, H., Blaschke, D., and Horz, W. (1993) Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen. Mol. Endocrinol. 7, 924-936.
44. Quigley, C. A., De Bellis, A., Marschke, K. B., el-Awady, M. K., Wilson, E. M., and French, F. S. (1995) Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr. Rev. 16, 271-321.
45. Kinoshita, H., Shi, Y., Sandefur, C., Meisner, L. F., Chang, C., Choon, A., Reznikoff, C. R., Bova, G. S., Friedl, A., and Jarrard, D. F. (2000) Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. Cancer Res. 60, 3623-3630.
46. Nakayama, T., Watanabe, M., Suzuki, H., Toyota, M., Sekita, N., Hirokawa, Y., Mizokami, A., Ito, H., Yatani, R., and Shiraishi, T. (2000) Epigenetic regulation of androgen receptor gene expression in human prostate cancers. Lab. Invest. 80, 1789-1796.
47. Fribourg, A. F., Knudsen, K. E., Strobeck, M. W., Lindhorst, C. M., and Knudsen, E. S. (2000) Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells. Cell. Growth. Differ. 11, 361-372.
48. Lu, S., Tsai, S. Y., and Tsai, M. J. (1997) Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. Cancer Res. 57, 4511-4516.
49. Lu, S., Liu, M., Epner, D. E., Tsai, S. Y., and Tsai, M. J. (1999) Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter. Mol. Endocrinol. 13, 376-384.
50. Lu, S., Jenster, G., and Epner, D. E. (2000) Androgen induction of cyclin-dependent kinase inhibitor p21 gene: role of androgen receptor and transcription factor Sp1 complex. Mol. Endocrinol. 14, 753-760.
51. Aaltomaa, S., Lipponen, P., Eskelinen, M., Ala-Opas, M., and Kosma, V. M. (1999) Prognostic value and expression of p21 (waf1/cip1) protein in prostate cancer. Prostate 39, 8-15.
52. Chen, Y., Robles, A. I., Martinez, L. A., Liu, F., Gimẽnez-Conti, I. B., and Conti, C. J. (1996) Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats. Cell Growth Differ. 7, 1571-1578.
53. Knudsen, K. E., Arden, K. C., and Cavenee, W. K. (1998) Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells. J. Biol. Chem. 273, 20213-20222.
54. Weinberg, R. A. (1995) The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
55. Dyson, N. (1998) The regulation of E2F by pRB-family proteins. Genes. Dev. 12, 2245-2262.
56. Cooney, K. A., Wetzel, J. C., Merajver, S. D., Macoska, J. A., Singleton, T. P., and Wojno, K. J. (1996) Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res. 56, 1142-1145.
57. Brooks, J. D., Bova, G. S., and Isaacs, W. B. (1995) Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas. Prostate 26, 35-39
58. Fiedler, U., Ehlers, W., Meye, A., Fussel, S., Faller, G., Schmidt, U., and Wirth, M. P. (2001) LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13. Anticancer Res. 21, 2341-2350.
59. Kubota, Y., Fujinami, K., Uemura, H., Dobashi, Y., Miyamoto, H., Iwasaki, Y., Kitamura, H., and Shuin, T. (1995) Retinoblastoma gene mutations in primary human prostate cancer. Prostate 27, 314-230.
60. Day, M. L., Foster, R. G., Day, K. C., Zhao, X., Humphrey, P., Swanson, P., Postigo, A. A., Zhang, S. H., and Dean, D. C. (1997) Cell anchorage regulates apoptosis through the retinoblastoma tumor suppressor/E2F pathway. J. Biol. Chem. 272, 8125-8128.
61. French, L. E., Hahne, M., Viard, I., Radlgruber, G., Zanone, R., Becker, K., Muller, C., and Tschopp, J. (1996) Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell. Biol. 133, 335-343.
62. English, H. F., Kyprianou, N., and Isaacs, J. T. (1989) Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration. Prostate 15, 233-250.
63. Kyprianou, N., and Isaacs, J. T. (1988) Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122, 552-562.
64. Kerr, J. F., Wyllie, A. H., and Currie, A. R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26, 239-257.
65. Wang, H., Grand, R. J., Milner, A. E., Armitage, R. J., Gordon, J., and Gregory, C. D. (1996) Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: relationship to the cell-cycle and role of the retinoblastoma protein. Oncogene 13, 373-379.
66. Meikrantz, W., and Schlegel, R. (1995) Apoptosis and the cell cycle. J. Cell Bio. 58, 160-174.
67. Santana, P., Pena, L. A., Haimovitz-Friedman, A., Martin, S., Green, D., McLoughlin, M., Cordon-Cardo, C., Schuchman, E. H., Fuks, Z., and Kolesnick, R. (1996) Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86, 189-199.
68. Berges, R. R., Furuya, Y., Remington, L., English, H. F., Jacks, T., and Isaacs, J. T. (1993) Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc. Natl. Acad. Sci. USA 90, 8910-8914.
69. Day, M. L., Wu, S., and Basler, J. W. (1993) Prostatic nerve growth factor inducible A gene binds a novel element in the retinoblastoma gene promoter. Cancer Res. 53, 5597-5599.
70. Talhouk, R. S., Bissell, M. J., and Werb, Z. (1992) Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J. Cell Biol. 118, 1271-1282.
71. Tenniswood, M. P., Guenette, R. S., Lakins, J., Mooibroek, M., Wong, P., and Welsh, J. E. (1992) Active cell death in hormone-dependent tissues. Cancer Metastasis Rev. 11, 197-220.
72. Frisch, S. M., and Screaton, R. A. (2001) Anoikis mechanisms. Curr. Opin. Cell. Biol. 13, 555-562.
73. Day, M. L., Zhao, X., Vallorosi, C. J., Putzi, M., Powell, C. T., Lin, C., and Day, K. C. (1999) E-cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway. J. Biol. Chem. 274, 9656-9664.
74. Ansonoff, M. A., and Etgen, A. M. (1998) Estradiol elevates protein kinase C catalytic activity in the preoptic area of female rats. Endocrinology 139, 3050-3056.
75. Marino, M., Pallottini, V., and Trentalance, A. (1998) Estrogens cause rapid activation of IP3-PKC-alpha signal transduction pathway in HEPG2 cells. Biochem. Biophys. Res. Comm. 245, 254-258.
76. Livneh, E., and Fishman, D. D. (1997) Linking protein kinase C to cell-cycle control European. J. Biochem. 248, 1-9.
77. Durham, J. P., Butcher, F. R., Teoh, T. S., Miller, R., and Mawhinney, M. G. (1986) Characterization and androgenic regulation of soluble protein kinases and protein phosphorylation in rat ventral prostate gland Arch. Biochem. Biophys. 244, 692-700.
78. Zhao, X., Gschwend, J. E., Powell, C. T., Foster, R. G., Day, K. C., and Day, M. L. (1997) Retinoblastoma protein-dependent growth signal conflict and caspase activity are required for protein kinase C-signaled apoptosis of prostate epithelial cells. J. Biol. Chem. 272, 22751-22757.
79. Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., and Rosen, J. M. (1995) Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA 92, 3439-3443.
80. Gingrich, J. R., Barrios, R. J., Morton, R. A., Boyce, B. F., DeMayo, F. J., Finegold, M. J., Angelopoulou, R., Rosen, J. M., and Greenberg, N. M. (1996) Metastatic prostate cancer in a transgenic mouse. Cancer Res. 56, 4096-4102.
81. Eng, M. H., Charles, L. G., Ross, B. D., Chrisp, C. E., Pienta, K. J., Greenberg, N. M., Hsu, C. X., and Sanda, M. G. (1999) Early castration reduces prostatic carcinogenesis in transgenic mice. Urology 54, 1112-1119.
82. Lu, J., and Danielsen, M. (1998) Differential regulation of androgen and glucocorticoid receptors by retinoblastoma protein. J. Biol. Chem. 273, 31528-31533.
83. Yeh, S., Miyamoto, H., Nishimura, K., Kang, H., Ludlow, J., Hsiao, P., Wang, C., Su, C., and Chang, C. (1998) Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells. Biochem. Biophys. Res. Comm. 248, 361-367.
84. Ling, M. T., Chan, K. W., and Choo, C. K. (2001) Androgen induces differentiation of a human papilloma-virus 16 E6/E7 immortalized prostate epithelial cell line. J. Endocrinol. 170, 287-296.